This analysis explores the relevance of the public limited company format as capital access evolves, suggesting changes for regulatory frameworks.
Private capital markets have blurred traditional lines in corporate finance, outflanking the company law ban on public offers of securities by private limited companies and the use of the public limited company (“Plc”) form as a hook for tailored requirements. With today’s policy focus being on improving access to capital for all companies, the company law ban on public offers has become a hindrance for companies that want to use innovative offer and trading platforms. The illogicality of using Plc form rather than trading status or company size for regulatory tailoring has also become more obvious. The multilayered nature of modern corporate publicness requires a different approach.
No takes yet. Share an insight, caveat, or question.
Eilís Ferran (2026) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: